Metabolic Indexes State Studing in Patients with Chronic Viral Hepatitis C
Received: 27-Jul-2012 / Accepted Date: 27-Aug-2018 / Published Date: 29-Aug-2012 DOI: 10.4172/2161-0681.1000125 /
Endogen intoxication trigger in acute hepatitis C is hepatic cells cytolysis caused by viral reproduction with
subsequent immune system reaction. All above mentioned needs further study of formation mechanisms in Chronic
Hepatitis C (CHC) and motivation of immunosuppressive therapy. So this research aim was to determine the monitoring
metabolic indexes state in patients with chronic viral hepatitis C and motivate such diagnostic criteria as significant
tests for controlling the endogen intoxication.
Materials and methods: For this purpose, in serum of patients with hepatitis C and conventionally healthy people
from control group the activity of enzymes were detected. To study the bioenergetics changes in serum lactate/pyruvate
and NAD/NADH+ correlation were investigated. Mentioned indexes detection was performed using photometric method
with a set of chemicals manufactured by firm “Filisit-Diagnosticum”, Ukraine. For determination of lactate and pyruvate
test kits produced by “Olveks”, Ukraine, were used according to manufacturer’s recommendations.
Results and discussion: Thus, the results of monitoring indexes study in patients with CHC have found multiple
organ disorders of metabolic processes based on membrane pathology. Inhibition of reduction synthesis bioenergetics
in human body and catabolic processes activation which are connected with the tension of many organs and tissues
that in turn leads to endogenous intoxication. That’s why monitoring indexes state determination is important in
evaluation of the course severity degree at CHC according to the level of endogen intoxication.
Keywords: Endogen intoxication; NAD/NADH+; Chronic hepatitis C
By frequency lesion population hepatitis C ranks second after influenza and other ARI as it is characterized by long latent course with the high probability of developing cirrhosis and hepatocellular carcinoma according to greater duration and severity of the process, the tendency to chronicity and prognosis of adverse effects [1-5].
Hepatitis C virus is recognized as a major factor in fibrosis and cirrhosis developing. Parenchymal damage of cell membranes may lead to metabolic disorders, which plays a major role of liver fibrosis formation in hepatitis C .
A wide range of possible consequences of HCV-infection from spontaneous recovery to decompensated Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC) involves complex multifaceted system of relations between human body and virus. Among them there are factors associated with virus (genotype, mutations, population heterogeneity, viremia level) and host (sex, age, infection route, infection course duration, genetic predisposition, immune system function state, comorbid background, etc.) [5-8].
Endogenic Intoxication (EI) trigger in acute hepatitis C is hepatic cells cytolysis caused by viral reproduction with subsequent immune system reaction. EI syndrome in acute viral hepatitis is accompanied by increasing of lipid peroxidation processes, disorders in antioxidant and immune system activity, blood cells damage, nervous system involvement. Gromashevska  approves that the metabolic disturbances that have universal significance in the development of pathology, such as lipid peroxidation activation, antioxidant system shifts, energy potential decreasing, hypoxia, are described in various pathological processes [1,9-11].
All above mentioned needs further study of formation mechanisms in Chronic Hepatitis C (CHC) and motivation of immunosuppressive therapy. So this research aim was to determine the monitoring metabolic indexes state in patients with chronic viral hepatitis C and motivate such diagnostic criteria as significant tests for controlling the endogenic intoxication.
Materials and Methods
Structural metabolic homeostasis study in patients with chronic hepatitis C was carried out by monitoring clinical and biochemical parameters determination. For this purpose, in serum of patients with hepatitis C (men and women aged from 15 to 60 years) and conventionally healthy people from control group the activity of enzymes (ALT, AST, γ-GTP, Alkaline Phosphatase (AP), and the content of total bilirubin, glucose, urease, kreatinine, total protein, cholesterol, High Density Lipoproteins (HDL), triglycerides, albumin were detected. To study the bioenergetic changes in serum lactate/ pyruvate and NAD/NADH+ correlation were investigated. Mentioned indexes detection was performed using photometric method with a set of chemicals manufactured by firm “Filisit-Diagnosticum”, Ukraine. For determination of lactate and pyruvate test kits produced by “Olveks”, Ukraine, were used according to manufacturer’s recommendations.
Method for determining lactate and pyruvate is based on enzymatic oxidation of lactic acid into pyruvic acid by lactate dehydrogenase while restoring NAD+ in NADH2. Equilibrium reaction is shifted toward the formation of lactic acid, but when you add hydrazine formed pyruvic acid can be bind completely. Lactic acid quantity is determined by the concentration of formed NADH after measuring optical density at 340 nm. Pyruvic acid quantity is expected according to decreasing in NADH concentration. NADH concentration (in micromole) in the sample is calculated according to formula: X = (Δ?340×V)/6.22, were (in which) Δ?340 changing in reaction mixture optical density, V-volume of sample in ml. NADH molar absorption coefficient at 340 nm is 6.22×103 M-1cm-1 .
110 patients with chronic viral hepatitis C we examined. Among them 50 patients were with manifestation form (MF CHC), 55 had latent form (LF CHC), 9 patients were with cirrhosis and 3 had hepatocellular carcinoma with a positive PCR result for HCV. In 63 patients were distinguished virus genotypes: 1b in 30 patients, 3a in 15, genotype 2 in 14 and 1a in 4 patients accordingly. Patient’s average age was 39.4 ± 3.2 years. Control group included 25 healthy people who had no history of liver disease. Statistical analysis of the results was performed by Student-Fischer indexes.
Results and Discussion
Structural metabolic homeostasis study in patients with chronic hepatitis C determined the increasing in average values of AST, ALT, γ-GTP, AP in comparison with control group. AST indexes were increased in 2.1, 2.0 and 1.5 accordingly at MF CHC, LF CHC and liver cirrhosis. Despite the fact that the average activity of AST increased in 1.5 times in CHC in comparison with control group the reliability of these differences has not been established. ALT increased in 2.3, 1.8 and 2.0 accordingly at MF CHC, LF CHC and liver cirrhosis. Similar dynamics was observed for γ-GTP activity which was increased in 2.3, 2.0 and 2.1 accordingly at MF CHC, LF CHC and liver cirrhosis. It should be noted that 2% of patients experienced a decrease and 21% an increase of alkaline phosphatase activity, which represented a significant number of patients with impaired function of this enzyme activity, but according to all studied groups the average index of alkaline phosphatase activity was also within the physiological norm. An increase of indirect bilirubin fraction was detected in 11.7% of patients with cirrhosis, in 8.3% with the LF CHC and in 8.7% with the MF CHC. These data indicate metabolic reorganization and tension of liver functions in patients with CHC (Table 1).
|Indexes||MF CHC (n=50)||LF CHC (n=55)||Cirrhosis (n=9)||HCC (n=3)||Control group (n=25)|
|АSТ (u/L)||38.6 ± 6.7*||29.3 ± 8.4||40.8 ± 9.2*||43.5 ± 8.7*||19.3 ± 4.6|
|АLТ (u/L)||40.4 ± 8.5*||27.8 ± 7.2||39.6 ± 8.1*||37.3 ± 9.6*||22.7 ± 4.6|
|γ-GTP (u/L)||54.2 ± 18.3*||45.3 ± 16.7||47.5 ± 14,9*||56.3 ± 12.6*||29.4 ± 7.2|
|AP (u/L)||1.92 ± 0.4*||1.86 ± 0.2*||2.6 ± 1.2*||2.4 ± 0.8*||2.2 ± 1.04|
|Bilirubin||25.1 ± 3.77||15.5 ± 0.63||32.6 ± 2.1*||34.3 ± 1.6*||16.5 ± 2.63|
Note: *differences are significant P<0.05.
Table 1: State of marker organspecific enzymes in patients with CHC depending on the form of the disease (M ± m).
The analysis of enzyme activity dynamics, their organic specificity, structural and metabolic role is allowed to determine the tension and involvement in pathological process of all internal organs, systems and body functions in the development of CHC. The appearance of membrane-structural enzymes in higher values in patients serum may indicate and reflect the development of membrane pathology in which dysfunction of nuclear-cytoplasmic interactions is formed, intracellular metabolism and bioenergetics processes are disturbed and it is important in the pathogenesis of hepatitis.
Study of major carbohydrates, protein and fat exchange metabolites in patients with CHC revealed disorders in serum content of urease, creatinine, total protein, albumin, cholesterol, HDL and triglycerides. There were no changes in glucose content at different forms of chronic hepatitis C. Urease was increased in 43%, 50% and 53% and creatinine was decreased in 32.4%, 42% and 36.2% accordingly at MF CHC, LF CHC and cirrhosis. In all cases there was an increasing in total protein and albumin contents. Thus, total protein was increased in 14.8%, 9.3%, and 18,9% in patients with MF CHC, LF CHC and cirrhosis. The same situation was with albumin concentration: at CHC it content was increased in 16%. Increasing in triglycerides content (264 ± 13.4 mg/dl) and decreasing in HDL quantity (28.2 ± 1.2 mg/dl) indicated lipid metabolism disorder and risk of liver fatty dystrophy formation. There was shown no differences in cholesterol indexes at patients with CHC and control group. Research has found disorders of protein and fat metabolism in patients with CHC at which it should be considered that catabolic processes predominate over anabolic (Table 2).
|Indexes||Research group (М ± m)|
|MF CHC (n=50)||LF CHC (n=55)||Cirrhosis (n=9)||HCC (n=3)||Control group (n=25)|
|Glucose (mmol/l)||4.1 ± 0.7||3.8 ± 0.5||3.9 ± 0.4||4.2 ± 0.8||4.4 ± 0.6|
|Urease (mmol/l)||8.9 ± 0.5*||9.3 ± 0.6*||9.7 ± 0.8*||9.5 ± 0.7*||6.2 ± 0.8*|
|Creatinine (mcmol/l)||51.6 ± 12.4*||44.5 ± 9.3*||48.7 ± 10.5*||46.8 ± 13.4*||76.3 ± 7.2|
|Total protein (g/l)||67.3 ± 5.2*||70.6 ± 3.7*||56.4 ± 2.2*||76.5 ± 2.8*||72.5 ± 6.4|
|Albumin (g/l)||32.4 ± 4.4*||36.3 ± 2.8*||30.5 ± 5.2*||64.4 ± 1.45*||48.4 ± 3.5|
|Cholesterol (mmol/l)||3.1 ± 0.17||2.7 ± 0.22*||2.5 ± 0.35||2.4 ± 0.40*||4.6 ± 0.25|
|Triglycerides (mmol/l)||2.5 ± 0.22*||2.7 ± 0.33*||2.6 ± 0.18*||2.8 ± 0.43*||1.7 ± 0.26|
Note: *differences are significant P<0.05
Table 2: State of major monitoring proteins and carbohydrates exchange metabolites in patients with CHC.
To detect bioenergetics changes we examined the ratio of pyruvic acid and lactate as markers of carbohydrate metabolism oxidative stage (the ratio of aerobic and anaerobic phases), and NAD+ and NADH2 levels as mandatory participants of oxidation-reduction reactions and regulators of cell metabolism. Decreased NADH2 index (0.002 ± 0.0001 mmol/l) was determined in comparison with control group (0.01+0.0005 mmol/l). The NAD+ concentration (0.494 ± 0.03 mmol/l) was significantly (P<0.05) increased at patients with CHC in comparison with normal content (Table 3). An increased content of oxidized nicotinamide coenzymes was detected in patients with CHC.
|MF CHC||LF CHC||Cirrhosis||HCC||Normal content|
|NAD+||0.48 ± 0.4*||0.36 ± 0.08*||0.58 ± 0.12**||0.65 ± 0,3**||0.126 ± 0.03|
|NADH2||0.008 ± 0.004*||0.002 ± 0.001*||0.003 ± 0.001**||0.0007 ± 0.0002**||0.01 ± 0.0005|
|NAD+ /NADH2||0.15 ± 0.028||0.12 ± 0.035||0.18 ± 0.04||0.21 ± 0.03||0.09 ± 0.02|
Note: *the difference is reliable in comparison with normal content, **the difference between the groups is significant
Table 3: NAD+ and NADH2 serum concentration in patients with CHC (mmol/l).
Increasing in the ratio of NAD+/NADH2 reduces the activity of NAD+ dependent enzymes in the cytosol and mitochondria. Restoration of dehydroxyacetonphosphate which is an intermediate metabolite of glycolysis and glyconeogenesis leads to inhibition of the last. Increased concentration of NADH2 compared with NAD+ slows lactate oxidation and increases the ratio of lactate/pyruvate resulting in even more slowdown of glyconeogenesis. Lactate concentration increases in the blood.
Pyruvate oxidative decarboxylation is accompanied by formation of NADH, which brings electrons to the respiratory chain and provides ATP synthesis. As the ratio of NAD+/NADH2 is relatively constant in cells so the increase in NADH concentration reduces the rate of pyruvate decarboxylation. Therefore, NAD+/NADH2 ratio change is an important indicator which reflects the energy needs of cells that regulate the rate of pyruvate oxidation decarboxylation. Catalytic activity of pyruvate dehydrogenase complex decreases when cells have enough fatty acids quantity that we observed in our study. Determined decrease of triglycerides and HDL contents in patients with CHC explains the accelerated use of fatty acids in terms of lipids peroxide oxidation.
Lactate and pyruvate parameters study has found the following. In patients of all groups lactate indexes exceeded the parameters of control group and amounted 2.12 ± 0.23 and 1.89 ± 0.45 mmol/l for MF CHC and LF CHC accordingly in comparison with control value (1.56 ± 0.235 mmol/l). Pyruvate serum indexes were significantly lower than in the control group (0.056 ± 0.011 mmol/l) and composed accordingly for MF CHC and LF CHC 0.031 ± 0.012 and 0.174 ± 0.01 mmol/l.
The increase of lactate concentration may be used like a stimulus for collagen synthesis in fibroblasts, which leads to accumulation of connective tissue in liver and cirrhosis development, and on it basis turns to tumor growth.
Thus, the results of monitoring indexes study in patients with CHC have found multiple organ disorders of metabolic processes based on membrane pathology.
Inhibition of reduction synthesis bioenergetics in human body and catabolic processes activation which are connected with the tension of many organs and tissues that in turn leads to endogenous intoxication. That’s why monitoring indexes state determination is important in evaluation of the course severity degree at CHC according to the level of EI.
- Ugriumov BL, Gromashevskaia LL, Tat'ianko NV, Vovk AD (1994) The clinical variants of viral hepatitis. Lik Sprava: 9-14.
- Gromashevskaia LL, Radzevich IM (1991) Complex forms of enzymes and prospects for their study (review of the literature). Lab Delo: 3-9.
- Nokhodian Z, Meshkati M, Adibi P, Ataei B, Kassaian N, et al. (2012) Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors. Int J Prev Med 3:S131-S138.
- Young AM, Crosby RA, Oser CB, Leukefeld CG, Stephens DB, et al. (2012) Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. J Med Virol 84: 1376-1387.
- Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M (2012) Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon 12: 339-343.
- Celton M, Goelzer A, Camarasa C, Fromion V, Dequin S (2012) A constraint-based model analysis of the metabolic consequences of increased NADPH oxidation in Saccharomyces cerevisiae. Metab Eng 14: 366-379.
- Leong DW, Komen JC, Hewitt CA, Arnaud E, McKenzie M, et al. (2012) Proteomic and Metabolomic Analyses of Mitochondrial Complex I-deficient Mouse Model Generated by Spontaneous B2 Short Interspersed Nuclear Element (SINE) Insertion into NADH Dehydrogenase (Ubiquinone) Fe-S Protein 4 (Ndufs4) Gene. J Biol Chem 287: 20652-20663.
- de Mochel NS, Seronello S, Wang SH, Ito C, Zheng JX, et al. (2010) Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 52: 47-59.
- Roe B, Kensicki E, Mohney R, Hall WW (2011) Metabolomic profile of hepatitis C virus-infected hepatocytes. PLoS One 6: e23641.
- Duygu F, Koruk ST, Karsen H, Aksoy N, Taskin A, et al. (2012) Prolidase and oxidative stress in chronic hepatitis C. J Clin Lab Anal 26: 232-237.
- Farias MS, Budni P, Ribeiro CM, Parisotto EB, Santos CE, et al. (2012) Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients. Gastroenterol Hepatol 35: 386-394.
- Choi J (2012) Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations. Free Radic Biol Med 52: 1135-1150.
Citation: Kozko VN, Zhukov VI, Gramatyuk SN, Mozgova YA (2012) Metabolic Indexes State Studing in Patients with Chronic Viral Hepatitis C. J Clin Exp Pathol 2:125. Doi: 10.4172/2161-0681.1000125
Copyright: © 2012 Kozko VN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 13253
- [From(publication date): 9-2012 - Dec 09, 2022]
- Breakdown by view type
- HTML page views: 9038
- PDF downloads: 4215